M Earl Balis

Title: M Earl Balis: Innovator in Cancer Treatment

Introduction

M Earl Balis is a notable inventor based in New York, NY (US), recognized for his contributions to cancer treatment through innovative methodologies. He holds 2 patents that focus on advanced techniques for detecting and treating tumors. His work has significant implications for improving patient outcomes in oncology.

Latest Patents

Balis's latest patents include a method for treating tumors with UDPG, which demonstrates tumor-specific inhibition of PRPP. This suggests that UDPG could be beneficial in combination therapy with inhibitors of purine and pyrimidine nucleotide synthesis in various rescue regimens. Additionally, he developed a process for detecting the presence of malignant and pre-malignant cells. This method involves contacting an antibody to oncofoetal deoxythymidine kinase with human cells and identifying cells containing the oncofoetal deoxythymidine kinase antigen bound to the antibody.

Career Highlights

Throughout his career, Balis has worked with prestigious institutions such as the Sloan-Kettering Institute and Memorial Hospital for Cancer and Allied Diseases. His research has contributed to the understanding and treatment of cancer, making a lasting impact in the field.

Collaborations

Balis has collaborated with esteemed colleagues, including Paul J Higgins and Josephine S Salser, further enhancing the scope and reach of his research efforts.

Conclusion

M Earl Balis's innovative work in cancer treatment and detection showcases his dedication to advancing medical science. His patents reflect a commitment to improving therapeutic strategies for patients facing malignancies.